| scholarly article | Q13442814 |
| P2093 | author name string | David Cunningham | |
| Ian Chau | |||
| David Watkins | |||
| Eleftheria Kalaitzaki | |||
| Olga Husson | |||
| Naureen Starling | |||
| Alexandros Georgiou | |||
| Sheela Rao | |||
| Kyriakos Kouvelakis | |||
| Vanessa Calamai | |||
| Anna Minchom | |||
| Penelope Edwards | |||
| Maria Ifijen | |||
| Natalie Nobar | |||
| Shelize Khakoo | |||
| P2860 | cites work | Early-onset colorectal cancer: a separate subset of colorectal cancer | Q27012841 |
| Cancer incidence and mortality worldwide: sources, methods and major patterns in GLOBOCAN 2012 | Q27861047 | ||
| The Rising Incidence of Younger Patients With Colorectal Cancer: Questions About Screening, Biology, and Treatment | Q30234889 | ||
| Early-onset colorectal cancer: a sporadic or inherited disease? | Q34207783 | ||
| FOLFOXIRI plus bevacizumab versus FOLFIRI plus bevacizumab as first-line treatment of patients with metastatic colorectal cancer: updated overall survival and molecular subgroup analyses of the open-label, phase 3 TRIBE study. | Q34492429 | ||
| Mismatch repair deficiency predicts response of solid tumors to PD-1 blockade. | Q34557699 | ||
| Adjuvant chemotherapy versus observation in patients with colorectal cancer: a randomised study. | Q34725978 | ||
| Screening for colorectal cancer in adults at average risk: a summary of the evidence for the U.S. Preventive Services Task Force | Q34740728 | ||
| Increasing disparities in the age-related incidences of colon and rectal cancers in the United States, 1975-2010. | Q36336606 | ||
| Association of age with survival in patients with metastatic colorectal cancer: analysis from the ARCAD Clinical Trials Program | Q36733282 | ||
| Increasing incidence of rectal cancer in patients aged younger than 40 years: an analysis of the surveillance, epidemiology, and end results database | Q36759517 | ||
| Impact of young age on treatment efficacy and safety in advanced colorectal cancer: a pooled analysis of patients from nine first-line phase III chemotherapy trials | Q36920315 | ||
| High Prevalence of Hereditary Cancer Syndromes in Adolescents and Young Adults With Colorectal Cancer | Q37163874 | ||
| Increasing Incidence of Colorectal Cancer in Adolescents and Young Adults Aged 15-39 Years in Western Australia 1982-2007: Examination of Colonoscopy History | Q38632906 | ||
| Colorectal cancer in the very young: a comparative study of tumor markers, pathology and survival in early onset and adult onset patients | Q39456150 | ||
| Colorectal Cancer Incidence Patterns in the United States, 1974-2013. | Q40258714 | ||
| Overtreatment of young adults with colon cancer: more intense treatments with unmatched survival gains. | Q41165285 | ||
| Clinical outcomes associated with bevacizumab-containing treatment of metastatic colorectal cancer: the BRiTE observational cohort study | Q43281857 | ||
| Diagnosis of colon cancer differs in younger versus older patients despite similar complaints | Q43811353 | ||
| The increasing incidence of young-onset colorectal cancer: a call to action | Q44287150 | ||
| Safety and efficacy of first-line bevacizumab with FOLFOX, XELOX, FOLFIRI and fluoropyrimidines in metastatic colorectal cancer: the BEAT study. | Q46029883 | ||
| Rectal cancer in young Indians--are these cancers different compared to their older counterparts? | Q46038714 | ||
| Circulating tumour DNA, a promising biomarker for the management of colorectal cancer | Q49836611 | ||
| 3 versus 6 months of adjuvant oxaliplatin-fluoropyrimidine combination therapy for colorectal cancer (SCOT): an international, randomised, phase 3, non-inferiority trial. | Q52610762 | ||
| Age at onset should be a major criterion for subclassification of colorectal cancer. | Q54399530 | ||
| Colorectal cancer | Q55924124 | ||
| Colorectal cancer screening for average-risk adults: 2018 guideline update from the American Cancer Society | Q56158704 | ||
| Early onset sporadic colorectal cancer: Worrisome trends and oncogenic features | Q56243439 | ||
| FOLFOXIRI plus bevacizumab as first-line treatment in BRAF mutant metastatic colorectal cancer | Q59218920 | ||
| Early-onset colorectal cancer in young individuals | Q61814377 | ||
| Clinical and Molecular Comparative Study of Colorectal Cancer Based on Age-of-onset and Tumor Location: Two Main Criteria for Subclassifying Colorectal Cancer | Q64040236 | ||
| Global Increasing Incidence of Young-Onset Colorectal Cancer Across 5 Continents: A Joinpoint Regression Analysis of 1,922,167 Cases | Q64108524 | ||
| Hereditary colorectal cancer | Q73088287 | ||
| Mechanisms of microsatellite instability in colorectal cancer patients in different age groups | Q82069037 | ||
| Left-Sided Dominance of Early-Onset Colorectal Cancers: A Rationale for Screening Flexible Sigmoidoscopy in the Young | Q88715264 | ||
| Primary tumor sidedness and benefit from FOLFOXIRI plus bevacizumab as initial therapy for metastatic colorectal cancer. Retrospective analysis of the TRIBE trial by GONO | Q89008321 | ||
| Increased incidence of colon cancer among individuals younger than 50 years: A 17 years analysis from the cancer registry of the municipality of Milan, Italy | Q90041988 | ||
| Increasing incidence of colorectal cancer in young adults in Europe over the last 25 years. | Q91013397 | ||
| Trends in Colorectal Cancer Incidence and Survival in Iowa SEER Data: The Timing of It All | Q91322384 | ||
| Colorectal cancer in young patients: a retrospective cohort study in a single institution | Q91984056 | ||
| A Summary of the Fight Colorectal Cancer Working Meeting: Exploring Risk Factors and Etiology of Sporadic Early-Age Onset Colorectal Cancer | Q92077753 | ||
| Clinical and molecular characterization of early-onset colorectal cancer | Q92259250 | ||
| State Variation in Early-Onset Colorectal Cancer in the United States, 1995-2015 | Q92374674 | ||
| ACORN: Observational Study of Bevacizumab in Combination With First-Line Chemotherapy for Treatment of Metastatic Colorectal Cancer in the UK | Q92880057 | ||
| Rising Proportion of Young Individuals With Rectal and Colon Cancer | Q93013674 | ||
| P275 | copyright license | Creative Commons Attribution 4.0 International | Q20007257 |
| P6216 | copyright status | copyrighted | Q50423863 |
| P433 | issue | 10 | |
| P921 | main subject | colorectal cancer | Q188874 |
| P577 | publication date | 2019-10-14 | |
| P1433 | published in | Cancers | Q27722963 |
| P1476 | title | Outcomes of Patients with Early Onset Colorectal Cancer Treated in a UK Specialist Cancer Center | |
| P478 | volume | 11 |
| Q99580406 | Non-anaemic iron deficiency should be investigated with the same priority as iron deficiency anaemia in fast track colorectal clinics-retrospective cohort study | cites work | P2860 |
Search more.